High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
This grant aims to support innovative research on the intersection of HIV and substance use, with the goal of advancing prevention, treatment, and cure efforts among people who use drugs. It is open to both individuals and research teams, covering a wide range of research areas.
Funder: National Institutes of Health
Due Dates: July 15, 2024 (Open Date) | August 15, 2024 | February 11, 2025 | August 15, 2025 | February 11, 2026 | June 5, 2026 | February 5, 2027 | March 5, 2027 (Final)
Funding Amounts: Up to $1.5M direct costs per year; max project period 5 years; 1–2 awards per year anticipated.
Summary: Supports interdisciplinary research teams pursuing transformative projects at the intersection of HIV and substance use, aligned with NIH HIV/AIDS research priorities.
Key Information: Requires 3–6 PD/PIs per application; foreign organizations are not eligible; preliminary data and detailed team management plan required.
Description
This NIH funding opportunity supports high-priority, interdisciplinary research at the intersection of HIV and substance use. The program seeks to catalyze transformative advances in HIV/AIDS research, particularly as it relates to prevention, treatment, and cure among people who use drugs (PWUD) or have substance use disorders (SUDs). Projects must be ambitious, innovative, and achievable only through the integrated efforts of a team of three to six principal investigators (PD/PIs), each bringing distinct expertise. The initiative covers a broad spectrum from basic science to clinical and implementation research, but all proposals must align with NIH HIV/AIDS research priorities and address a single, well-defined scientific goal.
